Sensitivity changes to morphine and other drugs induced by cholinergic blockade

Area of Science:

• Pharmacology
• Neuroscience
• Toxicology

Background:

• Atropine, an anticholinergic drug, can significantly alter neurotransmitter systems.
• Understanding atropine's effects on drug responses is crucial for clinical and research settings.

Purpose of the Study:

• To investigate the impact of high-dose atropine treatment and subsequent withdrawal on the pharmacological effects of various drugs in mice.
• To assess atropine's influence on the development of morphine tolerance.

Main Methods:

• Mice received multiple high-dose atropine injections.
• Following a 2-5 day withdrawal period, the effects of morphine, arecoline, amphetamine, pentylenetetrazol, reserpine, and hexobarbital were evaluated.
• Comparisons were made against saline-injected control groups.

Main Results:

• Reduced analgesic responses to morphine and arecoline were observed post-atropine withdrawal.
• A significant decrease in hexobarbital-induced sleeping time was noted.
• No significant alterations in the analgesic effects of amphetamine, the depressant effects of reserpine, or the convulsant effects of pentylenetetrazol were found.
• The study of atropine's influence on morphine tolerance was confounded by the reduced morphine analgesia.

Conclusions:

• High-dose atropine administration followed by withdrawal alters sensitivity to certain central nervous system-acting drugs in mice.
• Atropine withdrawal leads to diminished responses to specific cholinergic and opioid agonists.
• Further research is needed to fully elucidate atropine's complex interactions with drug tolerance and sensitivity.